General Biologicals Corporation (TPEX:4117)
9.16
-0.09 (-0.97%)
Sep 8, 2026, 1:45 PM CST
| Market Cap | 654.83M -33.3% |
| Revenue (ttm) | 260.23M +3.5% |
| Net Income | 518.98M |
| EPS | 7.64 |
| Shares Out | 70.79M |
| PE Ratio | 1.21 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 126,468 |
| Open | 9.55 |
| Previous Close | 9.25 |
| Day's Range | 9.12 - 9.73 |
| 52-Week Range | 3.50 - 17.85 |
| Beta | 0.57 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |